National HealthCare Corp. Hits New 52-Week High of USD 172.95

National HealthCare Corp. has reached a significant milestone by hitting a new 52-week high of USD 172.95 on March 2, 2026. This achievement underscores the company's strong performance in the hospital industry, particularly notable given its market capitalization of USD 2,449 million, categorizing it as a small-cap stock. Over the past year, National HealthCare Corp. has demonstrated impressive growth, with a performance increase of 108.74%, significantly outpacing the S&P 500's 17.36% gain during the same period. The company's price-to-earnings (P/E) ratio stands at 20.00, reflecting its valuation in the market. Additionally, National HealthCare Corp. offers a dividend yield of 1.60%, which may appeal to income-focused investors. With a return on equity of 9.30% and a price-to-book ratio of 2.33, the company showcases solid financial health. The stock's 52-week low was recorded at USD 89.14, highlighting the substantial upward movement in its price. This recent high marks a pivotal moment for National HealthCare Corp. as it continues to navigate the competitive landscape of the healthcare sector.